Spruce Biosciences, Inc. Tax Withholding Paid on Stock Awards
Spruce Biosciences, Inc. (SPRB) reported Tax Withholding Paid on Stock Awards of $10.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-12
- Spruce Biosciences, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $0.00.
- Spruce Biosciences, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $10.00K.
- Spruce Biosciences, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $831.00K, a 256.65% increase year-over-year.
- Spruce Biosciences, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $0.00.
- Spruce Biosciences, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $831.00K, a 237.80% increase from fiscal 2024.
- Spruce Biosciences, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $246.00K, a 20.90% decline from fiscal 2023.
- Spruce Biosciences, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $311.00K, a 677.50% increase from fiscal 2022.
- Spruce Biosciences, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $40.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $10.00K 10-Q · filed 2026-08-12 | $841.00K derived: sum of 3 quarters · filed 2026-08-12 | $841.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $10.00K 10-Q · filed 2026-05-13 | $841.00K derived: sum of 2 quarters · filed 2026-05-13 | $841.00K derived: sum of 3 quarters · filed 2026-05-13 | $841.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $831.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $831.00K derived: sum of 2 quarters · filed 2026-03-09 | $831.00K derived: sum of 3 quarters · filed 2026-08-12 | $831.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-12 | $0.00 10-Q · filed 2025-11-10 | $233.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | $233.00K derived: sum of 3 quarters · filed 2026-08-12 | $233.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | $233.00K derived: sum of 2 quarters · filed 2026-05-13 | $233.00K derived: sum of 3 quarters · filed 2026-05-13 | $244.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $233.00K derived: sum of 2 quarters · filed 2026-03-09 | $244.00K derived: sum of 3 quarters · filed 2026-03-09 | $246.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $11.00K derived: sum of 2 quarters · filed 2025-11-10 | $13.00K 10-Q · filed 2025-11-10 | $230.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $13.00K 10-Q · filed 2025-08-14 | $230.00K derived: sum of 3 quarters · filed 2025-08-14 | $230.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $2.00K 10-Q · filed 2025-05-06 | $219.00K derived: sum of 2 quarters · filed 2025-05-06 | $219.00K derived: sum of 3 quarters · filed 2025-05-06 | $290.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $217.00K derived: sum of 2 quarters · filed 2025-04-15 | $288.00K derived: sum of 3 quarters · filed 2025-04-15 | $311.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $71.00K derived: sum of 2 quarters · filed 2024-11-12 | $94.00K 10-Q · filed 2024-11-12 | $94.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $94.00K 10-Q · filed 2024-08-12 | $94.00K derived: sum of 3 quarters · filed 2024-08-12 | $134.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $23.00K 10-Q · filed 2024-05-13 | $23.00K derived: sum of 2 quarters · filed 2024-05-13 | $63.00K derived: sum of 3 quarters · filed 2024-05-13 | $63.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $40.00K derived: sum of 2 quarters · filed 2024-03-18 | $40.00K derived: sum of 3 quarters · filed 2024-03-18 | $40.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $40.00K derived: sum of 2 quarters · filed 2023-11-13 | $40.00K 10-Q · filed 2023-11-13 | $40.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $0.00 derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |